nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—C1QBP—breast cancer	0.0229	0.0951	CbGpPWpGaD
Fondaparinux sodium—F10—Extrinsic Pathway—F3—breast cancer	0.0229	0.095	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—C1QBP—breast cancer	0.0154	0.0641	CbGpPWpGaD
Fondaparinux sodium—F10—mammary gland—breast cancer	0.014	0.219	CbGeAlD
Fondaparinux sodium—F10—Intrinsic Pathway—C1QBP—breast cancer	0.0129	0.0537	CbGpPWpGaD
Fondaparinux sodium—F10—nipple—breast cancer	0.0116	0.181	CbGeAlD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINB2—breast cancer	0.00897	0.0373	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—C1QBP—breast cancer	0.00873	0.0362	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F3—breast cancer	0.00834	0.0346	CbGpPWpGaD
Fondaparinux sodium—F10—endometrium—breast cancer	0.007	0.109	CbGeAlD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FLT1—breast cancer	0.00675	0.028	CbGpPWpGaD
Fondaparinux sodium—F10—adipose tissue—breast cancer	0.00631	0.0986	CbGeAlD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—TGFBI—breast cancer	0.00586	0.0243	CbGpPWpGaD
Fondaparinux sodium—F10—female reproductive system—breast cancer	0.0058	0.0907	CbGeAlD
Fondaparinux sodium—F10—adrenal gland—breast cancer	0.00566	0.0885	CbGeAlD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F3—breast cancer	0.00562	0.0233	CbGpPWpGaD
Fondaparinux sodium—F10—female gonad—breast cancer	0.00528	0.0825	CbGeAlD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFBR2—breast cancer	0.00526	0.0218	CbGpPWpGaD
Fondaparinux sodium—F10—endocrine gland—breast cancer	0.00491	0.0767	CbGeAlD
Fondaparinux sodium—SERPINC1—Glypican 1 network—NRG1—breast cancer	0.00474	0.0197	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F3—breast cancer	0.00471	0.0196	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGFR1—breast cancer	0.00414	0.0172	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLG—breast cancer	0.00363	0.0151	CbGpPWpGaD
Fondaparinux sodium—F10—lymph node—breast cancer	0.00339	0.053	CbGeAlD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F3—breast cancer	0.00317	0.0132	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAUR—breast cancer	0.00298	0.0124	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAUR—breast cancer	0.00298	0.0124	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLG—breast cancer	0.00292	0.0121	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLAU—breast cancer	0.0026	0.0108	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GUCY1A2—breast cancer	0.00246	0.0102	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—SRC—breast cancer	0.0022	0.00915	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—breast cancer	0.00215	0.00891	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAU—breast cancer	0.00209	0.0087	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAU—breast cancer	0.00209	0.00867	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINE1—breast cancer	0.00201	0.00837	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HRG—breast cancer	0.00201	0.00833	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—breast cancer	0.00197	0.00818	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—C1QBP—breast cancer	0.00186	0.00774	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAUR—breast cancer	0.00169	0.00701	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLG—breast cancer	0.00165	0.00685	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINE1—breast cancer	0.00162	0.00673	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAD51B—breast cancer	0.00152	0.00631	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GUCY1A2—breast cancer	0.00139	0.00577	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINB2—breast cancer	0.00129	0.00537	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAD51C—breast cancer	0.00129	0.00537	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PDE2A—breast cancer	0.00126	0.00523	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KDM1A—breast cancer	0.0012	0.00499	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAU—breast cancer	0.00118	0.00491	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—STIM1—breast cancer	0.00115	0.00478	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HRG—breast cancer	0.00113	0.00471	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—C1QBP—breast cancer	0.00105	0.00437	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—F3—breast cancer	0.00101	0.00418	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGFBP5—breast cancer	0.000974	0.00405	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—ADAMTS1—breast cancer	0.000943	0.00392	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—MUC2—breast cancer	0.000917	0.00381	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINE1—breast cancer	0.000915	0.0038	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EEF1B2—breast cancer	0.000891	0.0037	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAD51B—breast cancer	0.000859	0.00357	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CFL1—breast cancer	0.00084	0.00349	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GRB7—breast cancer	0.000833	0.00346	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALDOA—breast cancer	0.000786	0.00326	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFC—breast cancer	0.000786	0.00326	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAD51C—breast cancer	0.00073	0.00303	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINB2—breast cancer	0.00073	0.00303	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PDE2A—breast cancer	0.000711	0.00296	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KDM1A—breast cancer	0.000679	0.00282	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ATF4—breast cancer	0.000675	0.00281	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB2—breast cancer	0.000661	0.00275	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—THBS1—breast cancer	0.000658	0.00273	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—STIM1—breast cancer	0.000651	0.0027	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GATA3—breast cancer	0.000649	0.00269	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—THBS1—breast cancer	0.000616	0.00256	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EIF2S2—breast cancer	0.000608	0.00253	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNB1—breast cancer	0.000582	0.00242	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F3—breast cancer	0.000569	0.00236	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—INHBB—breast cancer	0.00056	0.00232	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CCT5—breast cancer	0.00056	0.00232	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAUR—breast cancer	0.000535	0.00222	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EEF2—breast cancer	0.000534	0.00222	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLG—breast cancer	0.000523	0.00217	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPL31—breast cancer	0.000502	0.00209	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PLAUR—breast cancer	0.000501	0.00208	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PDGFA—breast cancer	0.000496	0.00206	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITPR1—breast cancer	0.000481	0.002	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ABL1—breast cancer	0.000478	0.00199	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CFL1—breast cancer	0.000475	0.00197	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GRB7—breast cancer	0.00047	0.00195	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPS4X—breast cancer	0.000468	0.00194	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—DDIT3—breast cancer	0.000461	0.00191	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EIF3A—breast cancer	0.000461	0.00191	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLA2G4A—breast cancer	0.00045	0.00187	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HGF—breast cancer	0.00045	0.00187	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ADAMTS1—breast cancer	0.000447	0.00186	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CSF2—breast cancer	0.000445	0.00185	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFC—breast cancer	0.000444	0.00184	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALDOA—breast cancer	0.000444	0.00184	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MUC2—breast cancer	0.000435	0.00181	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PABPC1—breast cancer	0.000414	0.00172	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MME—breast cancer	0.000409	0.0017	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TUBB3—breast cancer	0.000405	0.00168	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MMP1—breast cancer	0.000382	0.00159	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPL23A—breast cancer	0.00038	0.00158	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAU—breast cancer	0.000375	0.00156	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CDK2—breast cancer	0.000375	0.00156	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TGFB2—breast cancer	0.000374	0.00155	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—THBS1—breast cancer	0.000372	0.00154	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GATA3—breast cancer	0.000367	0.00152	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CAV1—breast cancer	0.000367	0.00152	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPS7—breast cancer	0.000355	0.00147	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPS8—breast cancer	0.000355	0.00147	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—FN1—breast cancer	0.000349	0.00145	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS2—breast cancer	0.000345	0.00143	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CG—breast cancer	0.000334	0.00139	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EGF—breast cancer	0.00033	0.00137	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNB1—breast cancer	0.000329	0.00137	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGFBP3—breast cancer	0.000321	0.00134	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ACHE—breast cancer	0.000314	0.0013	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF1—breast cancer	0.000306	0.00127	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT2—breast cancer	0.000305	0.00127	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAUR—breast cancer	0.000302	0.00126	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CTSD—breast cancer	0.000297	0.00123	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLG—breast cancer	0.000295	0.00123	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CD—breast cancer	0.000293	0.00122	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—THBS1—breast cancer	0.000293	0.00122	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE1—breast cancer	0.00029	0.00121	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALB—breast cancer	0.00029	0.0012	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PDGFA—breast cancer	0.00028	0.00116	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS3—breast cancer	0.000277	0.00115	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—BCHE—breast cancer	0.000273	0.00114	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITPR1—breast cancer	0.000272	0.00113	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ABL1—breast cancer	0.00027	0.00112	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPS6—breast cancer	0.000267	0.00111	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAF1—breast cancer	0.000262	0.00109	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CB—breast cancer	0.000256	0.00106	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TCF7L2—breast cancer	0.000254	0.00106	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLA2G4A—breast cancer	0.000254	0.00106	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HGF—breast cancer	0.000254	0.00106	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CSF2—breast cancer	0.000251	0.00104	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PLAUR—breast cancer	0.000238	0.000988	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL2—breast cancer	0.000235	0.000976	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PLG—breast cancer	0.000232	0.000965	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MMP1—breast cancer	0.000216	0.000897	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CDK2—breast cancer	0.000212	0.000881	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAU—breast cancer	0.000212	0.000881	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CAV1—breast cancer	0.000207	0.00086	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SRC—breast cancer	0.000205	0.000851	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—breast cancer	0.0002	0.000829	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—FN1—breast cancer	0.000197	0.000819	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS2—breast cancer	0.000195	0.000809	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MAPK3—breast cancer	0.000189	0.000784	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CG—breast cancer	0.000189	0.000784	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—EGF—breast cancer	0.000186	0.000774	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—breast cancer	0.000183	0.000761	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IGF1—breast cancer	0.000173	0.000717	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT2—breast cancer	0.000173	0.000717	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP1—breast cancer	0.00017	0.000706	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KRAS—breast cancer	0.00017	0.000705	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CD—breast cancer	0.000166	0.000689	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LEP—breast cancer	0.000164	0.000683	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINE1—breast cancer	0.000164	0.000681	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALB—breast cancer	0.000164	0.00068	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS3—breast cancer	0.000157	0.00065	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CA—breast cancer	0.000156	0.000648	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—breast cancer	0.000151	0.000627	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAF1—breast cancer	0.000148	0.000615	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CB—breast cancer	0.000145	0.0006	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HRAS—breast cancer	0.000144	0.000599	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGF1—breast cancer	0.000136	0.000564	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL2—breast cancer	0.000133	0.000551	CbGpPWpGaD
Fondaparinux sodium—Haematuria—Doxorubicin—breast cancer	0.000133	0.000191	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Paclitaxel—breast cancer	0.000133	0.000191	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Paclitaxel—breast cancer	0.000133	0.000191	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—breast cancer	0.000132	0.000189	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—MMP2—breast cancer	0.000131	0.000546	CbGpPWpGaD
Fondaparinux sodium—Epistaxis—Doxorubicin—breast cancer	0.000131	0.000189	CcSEcCtD
Fondaparinux sodium—Anorexia—Capecitabine—breast cancer	0.000131	0.000189	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—breast cancer	0.000131	0.000188	CcSEcCtD
Fondaparinux sodium—Vomiting—Irinotecan—breast cancer	0.000131	0.000188	CcSEcCtD
Fondaparinux sodium—Vomiting—Mitoxantrone—breast cancer	0.000131	0.000188	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—breast cancer	0.00013	0.000187	CcSEcCtD
Fondaparinux sodium—Dizziness—Fluorouracil—breast cancer	0.00013	0.000187	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—breast cancer	0.00013	0.000187	CcSEcCtD
Fondaparinux sodium—Rash—Mitoxantrone—breast cancer	0.00013	0.000187	CcSEcCtD
Fondaparinux sodium—Rash—Irinotecan—breast cancer	0.00013	0.000187	CcSEcCtD
Fondaparinux sodium—Dermatitis—Irinotecan—breast cancer	0.00013	0.000186	CcSEcCtD
Fondaparinux sodium—Dermatitis—Mitoxantrone—breast cancer	0.00013	0.000186	CcSEcCtD
Fondaparinux sodium—Headache—Mitoxantrone—breast cancer	0.000129	0.000185	CcSEcCtD
Fondaparinux sodium—Headache—Irinotecan—breast cancer	0.000129	0.000185	CcSEcCtD
Fondaparinux sodium—Hypotension—Capecitabine—breast cancer	0.000129	0.000185	CcSEcCtD
Fondaparinux sodium—Insomnia—Docetaxel—breast cancer	0.000129	0.000185	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Docetaxel—breast cancer	0.000128	0.000184	CcSEcCtD
Fondaparinux sodium—Vomiting—Gemcitabine—breast cancer	0.000127	0.000183	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—breast cancer	0.000127	0.000529	CbGpPWpGaD
Fondaparinux sodium—Dyspnoea—Docetaxel—breast cancer	0.000127	0.000182	CcSEcCtD
Fondaparinux sodium—Somnolence—Docetaxel—breast cancer	0.000126	0.000182	CcSEcCtD
Fondaparinux sodium—Rash—Gemcitabine—breast cancer	0.000126	0.000182	CcSEcCtD
Fondaparinux sodium—Dermatitis—Gemcitabine—breast cancer	0.000126	0.000182	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—breast cancer	0.000126	0.000181	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—breast cancer	0.000126	0.000181	CcSEcCtD
Fondaparinux sodium—Headache—Gemcitabine—breast cancer	0.000126	0.000181	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—breast cancer	0.000125	0.00018	CcSEcCtD
Fondaparinux sodium—Vomiting—Fluorouracil—breast cancer	0.000125	0.00018	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Docetaxel—breast cancer	0.000125	0.00018	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—breast cancer	0.000125	0.00018	CcSEcCtD
Fondaparinux sodium—Insomnia—Capecitabine—breast cancer	0.000125	0.000179	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—breast cancer	0.000124	0.000179	CcSEcCtD
Fondaparinux sodium—Rash—Fluorouracil—breast cancer	0.000124	0.000179	CcSEcCtD
Fondaparinux sodium—Dermatitis—Fluorouracil—breast cancer	0.000124	0.000179	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Capecitabine—breast cancer	0.000124	0.000178	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Docetaxel—breast cancer	0.000124	0.000178	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Paclitaxel—breast cancer	0.000124	0.000178	CcSEcCtD
Fondaparinux sodium—Headache—Fluorouracil—breast cancer	0.000123	0.000178	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—breast cancer	0.000123	0.000177	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—breast cancer	0.000123	0.000177	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Docetaxel—breast cancer	0.000123	0.000177	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Capecitabine—breast cancer	0.000123	0.000177	CcSEcCtD
Fondaparinux sodium—Fatigue—Docetaxel—breast cancer	0.000123	0.000176	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—breast cancer	0.000122	0.000176	CcSEcCtD
Fondaparinux sodium—Nausea—Irinotecan—breast cancer	0.000122	0.000176	CcSEcCtD
Fondaparinux sodium—Nausea—Mitoxantrone—breast cancer	0.000122	0.000176	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—breast cancer	0.000122	0.000175	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—breast cancer	0.000122	0.000175	CcSEcCtD
Fondaparinux sodium—Constipation—Docetaxel—breast cancer	0.000122	0.000175	CcSEcCtD
Fondaparinux sodium—Pain—Docetaxel—breast cancer	0.000122	0.000175	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—breast cancer	0.000121	0.000175	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Capecitabine—breast cancer	0.000121	0.000174	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—breast cancer	0.000121	0.000173	CcSEcCtD
Fondaparinux sodium—Asthenia—Paclitaxel—breast cancer	0.00012	0.000173	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Capecitabine—breast cancer	0.00012	0.000172	CcSEcCtD
Fondaparinux sodium—Nausea—Gemcitabine—breast cancer	0.000119	0.000171	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Capecitabine—breast cancer	0.000119	0.000171	CcSEcCtD
Fondaparinux sodium—Fatigue—Capecitabine—breast cancer	0.000119	0.000171	CcSEcCtD
Fondaparinux sodium—Pruritus—Paclitaxel—breast cancer	0.000119	0.000171	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—breast cancer	0.000118	0.00017	CcSEcCtD
Fondaparinux sodium—Pain—Capecitabine—breast cancer	0.000118	0.000169	CcSEcCtD
Fondaparinux sodium—Constipation—Capecitabine—breast cancer	0.000118	0.000169	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—breast cancer	0.000118	0.000169	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Docetaxel—breast cancer	0.000117	0.000169	CcSEcCtD
Fondaparinux sodium—Nausea—Fluorouracil—breast cancer	0.000117	0.000168	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Docetaxel—breast cancer	0.000116	0.000167	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—breast cancer	0.000116	0.000167	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—breast cancer	0.000116	0.000167	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—SRC—breast cancer	0.000116	0.000481	CbGpPWpGaD
Fondaparinux sodium—Flatulence—Epirubicin—breast cancer	0.000116	0.000167	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—breast cancer	0.000115	0.000166	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Paclitaxel—breast cancer	0.000115	0.000165	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—breast cancer	0.000114	0.000163	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Capecitabine—breast cancer	0.000113	0.000163	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—breast cancer	0.000113	0.000163	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—breast cancer	0.000113	0.000162	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—breast cancer	0.000113	0.000162	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—VEGFA—breast cancer	0.000113	0.000469	CbGpPWpGaD
Fondaparinux sodium—Gastrointestinal pain—Capecitabine—breast cancer	0.000113	0.000162	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—breast cancer	0.000113	0.000162	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Docetaxel—breast cancer	0.000112	0.000162	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Docetaxel—breast cancer	0.000112	0.000162	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—breast cancer	0.000112	0.00016	CcSEcCtD
Fondaparinux sodium—Dizziness—Paclitaxel—breast cancer	0.000111	0.00016	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—breast cancer	0.000111	0.000159	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—breast cancer	0.00011	0.000158	CcSEcCtD
Fondaparinux sodium—Urticaria—Capecitabine—breast cancer	0.000109	0.000157	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—CXCL8—breast cancer	0.000109	0.000454	CbGpPWpGaD
Fondaparinux sodium—Abdominal pain—Capecitabine—breast cancer	0.000109	0.000157	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Capecitabine—breast cancer	0.000109	0.000157	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—breast cancer	0.000109	0.000156	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—breast cancer	0.000109	0.000156	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—breast cancer	0.000109	0.000156	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—breast cancer	0.000107	0.000154	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—breast cancer	0.000107	0.000154	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—MAPK3—breast cancer	0.000107	0.000443	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Paclitaxel—breast cancer	0.000107	0.000153	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—breast cancer	0.000106	0.000153	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000106	0.000153	CcSEcCtD
Fondaparinux sodium—Rash—Paclitaxel—breast cancer	0.000106	0.000152	CcSEcCtD
Fondaparinux sodium—Dermatitis—Paclitaxel—breast cancer	0.000106	0.000152	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—breast cancer	0.000106	0.000152	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—breast cancer	0.000105	0.000152	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—breast cancer	0.000105	0.000151	CcSEcCtD
Fondaparinux sodium—Headache—Paclitaxel—breast cancer	0.000105	0.000151	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Docetaxel—breast cancer	0.000105	0.000151	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—breast cancer	0.000104	0.000149	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TGFB1—breast cancer	0.000104	0.00043	CbGpPWpGaD
Fondaparinux sodium—Confusional state—Methotrexate—breast cancer	0.000103	0.000149	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—breast cancer	0.000103	0.000149	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—breast cancer	0.000103	0.000147	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—breast cancer	0.000102	0.000147	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—breast cancer	0.000102	0.000147	CcSEcCtD
Fondaparinux sodium—Asthenia—Docetaxel—breast cancer	0.000102	0.000147	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—breast cancer	0.000102	0.000146	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—breast cancer	0.000102	0.000146	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Capecitabine—breast cancer	0.000101	0.000146	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—CTNNB1—breast cancer	0.000101	0.000419	CbGpPWpGaD
Fondaparinux sodium—Pruritus—Docetaxel—breast cancer	0.000101	0.000145	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—breast cancer	0.000101	0.000145	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—breast cancer	0.000101	0.000145	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—breast cancer	0.0001	0.000144	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—breast cancer	0.0001	0.000144	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—breast cancer	9.97e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Nausea—Paclitaxel—breast cancer	9.96e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—breast cancer	9.95e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.94e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—breast cancer	9.91e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Asthenia—Capecitabine—breast cancer	9.88e-05	0.000142	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—breast cancer	9.77e-05	0.000141	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—breast cancer	9.77e-05	0.000141	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—breast cancer	9.75e-05	0.00014	CcSEcCtD
Fondaparinux sodium—Pruritus—Capecitabine—breast cancer	9.74e-05	0.00014	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Docetaxel—breast cancer	9.73e-05	0.00014	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—breast cancer	9.67e-05	0.000139	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—breast cancer	9.61e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—breast cancer	9.59e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—breast cancer	9.59e-05	0.000138	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—KRAS—breast cancer	9.59e-05	0.000398	CbGpPWpGaD
Fondaparinux sodium—Hypotension—Methotrexate—breast cancer	9.58e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—breast cancer	9.56e-05	0.000137	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—breast cancer	9.53e-05	0.000137	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—breast cancer	9.49e-05	0.000136	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—breast cancer	9.44e-05	0.000136	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—breast cancer	9.42e-05	0.000136	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Capecitabine—breast cancer	9.42e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—breast cancer	9.41e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Dizziness—Docetaxel—breast cancer	9.4e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—breast cancer	9.39e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—breast cancer	9.36e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—breast cancer	9.32e-05	0.000134	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—breast cancer	9.27e-05	0.000133	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—breast cancer	9.27e-05	0.000133	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—breast cancer	9.26e-05	0.000133	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—breast cancer	9.23e-05	0.000133	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—breast cancer	9.2e-05	0.000132	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.19e-05	0.000132	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—breast cancer	9.14e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—breast cancer	9.14e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—breast cancer	9.11e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Dizziness—Capecitabine—breast cancer	9.1e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Vomiting—Docetaxel—breast cancer	9.04e-05	0.00013	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—breast cancer	9.02e-05	0.00013	CcSEcCtD
Fondaparinux sodium—Rash—Docetaxel—breast cancer	8.97e-05	0.000129	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—breast cancer	8.96e-05	0.000129	CcSEcCtD
Fondaparinux sodium—Dermatitis—Docetaxel—breast cancer	8.96e-05	0.000129	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—breast cancer	8.95e-05	0.000129	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—breast cancer	8.91e-05	0.000128	CcSEcCtD
Fondaparinux sodium—Headache—Docetaxel—breast cancer	8.91e-05	0.000128	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—breast cancer	8.87e-05	0.000128	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—breast cancer	8.87e-05	0.000128	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—breast cancer	8.85e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—breast cancer	8.84e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—breast cancer	8.82e-05	0.000127	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PIK3CA—breast cancer	8.81e-05	0.000366	CbGpPWpGaD
Fondaparinux sodium—Pain—Methotrexate—breast cancer	8.76e-05	0.000126	CcSEcCtD
Fondaparinux sodium—Vomiting—Capecitabine—breast cancer	8.75e-05	0.000126	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—breast cancer	8.73e-05	0.000126	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—breast cancer	8.7e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—breast cancer	8.69e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Rash—Capecitabine—breast cancer	8.68e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—breast cancer	8.67e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Dermatitis—Capecitabine—breast cancer	8.67e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—breast cancer	8.66e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Headache—Capecitabine—breast cancer	8.62e-05	0.000124	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—breast cancer	8.62e-05	0.000124	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—breast cancer	8.61e-05	0.000124	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—breast cancer	8.58e-05	0.000123	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—breast cancer	8.55e-05	0.000123	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—breast cancer	8.53e-05	0.000123	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TP53—breast cancer	8.52e-05	0.000354	CbGpPWpGaD
Fondaparinux sodium—Anorexia—Doxorubicin—breast cancer	8.46e-05	0.000122	CcSEcCtD
Fondaparinux sodium—Nausea—Docetaxel—breast cancer	8.45e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—breast cancer	8.45e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—breast cancer	8.44e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—breast cancer	8.38e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—breast cancer	8.34e-05	0.00012	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—breast cancer	8.29e-05	0.000119	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—breast cancer	8.28e-05	0.000119	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—breast cancer	8.27e-05	0.000119	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—breast cancer	8.2e-05	0.000118	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—breast cancer	8.2e-05	0.000118	CcSEcCtD
Fondaparinux sodium—Nausea—Capecitabine—breast cancer	8.18e-05	0.000118	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—HRAS—breast cancer	8.15e-05	0.000339	CbGpPWpGaD
Fondaparinux sodium—Urticaria—Methotrexate—breast cancer	8.14e-05	0.000117	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—breast cancer	8.1e-05	0.000117	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—breast cancer	8.1e-05	0.000117	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—breast cancer	8.03e-05	0.000115	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—breast cancer	7.97e-05	0.000115	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—breast cancer	7.91e-05	0.000114	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—breast cancer	7.9e-05	0.000114	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—breast cancer	7.89e-05	0.000113	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—breast cancer	7.84e-05	0.000113	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—breast cancer	7.81e-05	0.000112	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—breast cancer	7.71e-05	0.000111	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—breast cancer	7.66e-05	0.00011	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—breast cancer	7.65e-05	0.00011	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—breast cancer	7.62e-05	0.00011	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—breast cancer	7.59e-05	0.000109	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—breast cancer	7.59e-05	0.000109	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—breast cancer	7.58e-05	0.000109	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—breast cancer	7.58e-05	0.000109	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—breast cancer	7.55e-05	0.000109	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—breast cancer	7.35e-05	0.000106	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—breast cancer	7.31e-05	0.000105	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—breast cancer	7.26e-05	0.000104	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—breast cancer	7.25e-05	0.000104	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—AKT1—breast cancer	7.2e-05	0.000299	CbGpPWpGaD
Fondaparinux sodium—Hypersensitivity—Epirubicin—breast cancer	7.07e-05	0.000102	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—breast cancer	7.05e-05	0.000101	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—breast cancer	7.02e-05	0.000101	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—breast cancer	7.02e-05	0.000101	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—breast cancer	7.01e-05	0.000101	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—breast cancer	6.88e-05	9.9e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—breast cancer	6.79e-05	9.76e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—breast cancer	6.78e-05	9.75e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—breast cancer	6.56e-05	9.44e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—breast cancer	6.54e-05	9.4e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—breast cancer	6.52e-05	9.37e-05	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—breast cancer	6.46e-05	9.29e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—breast cancer	6.46e-05	9.29e-05	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—breast cancer	6.42e-05	9.23e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—breast cancer	6.37e-05	9.16e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—breast cancer	6.34e-05	9.12e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—breast cancer	6.28e-05	9.03e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—breast cancer	6.1e-05	8.77e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—breast cancer	6.09e-05	8.76e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—breast cancer	6.07e-05	8.73e-05	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—breast cancer	6.05e-05	8.7e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—breast cancer	6.04e-05	8.69e-05	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—breast cancer	6.01e-05	8.64e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—breast cancer	5.87e-05	8.44e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—breast cancer	5.7e-05	8.19e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—breast cancer	5.64e-05	8.12e-05	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—breast cancer	5.6e-05	8.05e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—breast cancer	5.59e-05	8.04e-05	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—breast cancer	5.56e-05	8e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—breast cancer	5.27e-05	7.58e-05	CcSEcCtD
